Evry, France

Novagali Pharma Sa


USPTO Granted Patents = 10

% Expired Patents = 40.0



Forward Citations = 45

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Gregory Lambert (7 out of 23 patents)

silverMedal Betty Philips (7 out of 16 patents)

bronzeMedal Laura Rabinovich-Guilatt (6 out of 14 patents)

4.  Frederic Lallemand (3 out of 14 patents)

5.  Jean-Sébastien Garrigue (3 out of 7 patents)

6.  Séverine Bague (3 out of 3 patents)

7.  Laura Rabinovich-Guilatti (2 out of 2 patents)

8.  Grégory Lambert (2 out of 2 patents)

9.  Frédéric Lallemand (1 out of 4 patents)

10.  Severine Bague (1 out of 1 patent)

11.  Scott Gibson (1 out of 1 patent)

12.  Grégory Lambert (1 patent)

13.  Francine Behar-Cohen (21 patents)

14.  Simon Benita (11 patents)

15.  Jeffrey Heier (1 patent)


10 patents:

Company Overview
Novagali Pharma SA is a biopharmaceutical company based in Evry, France, specializing in the development of innovative ophthalmic therapies. The company focuses on addressing unmet medical needs in eye care through its proprietary drug delivery technologies. Novagali Pharma is dedicated to advancing treatments for various ocular conditions, leveraging its expertise in formulation science and clinical development to enhance patient outcomes and improve the quality of life for individuals with eye diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#9 in Evry

#1,710 in France

#56,047 in the World

Evry, FR
Evry, France
Forward Citations = 45

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novagali Pharma Sa. Retrieved from https://idiyas.com/company/novagali-pharma-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…